A Phase 3 interventional study of PRP injection and VIU in Stricture Urethra, sponsored by Benha University. Completed at 1 site in Egypt. Open to male participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-09-23.
Sponsored by Benha University · Phase 3, Interventional, and Treatment
The effect of platelet rich plasma injection on post internal urethrotomy stricture recurrence
72 studies on the registry are indexed under Urethral Stricture; 25 are open to participants now.
This study's enrollment of 156 is above the median of 60 across 56 interventional studies indexed under Urethral Stricture.
Browse Urethral Stricture studies →Benha University is the lead sponsor of 362 studies on the registry; 66 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug: PRP injection
Procedure: VIU
The effect of platelet rich plasma injection on post internal urethrotomy stricture recurrence
VIU in stricture urethra
Post-voiding residual urine volume (PVR)
Post-voiding residual urine volume will be measured by ultrasonography , Unit of Measure : ml .
Time frame: 2 weeks
Maximum urinary flow rate (Qmax)
Maximum urinary flow rate will be assessed by uroflowmetry , Unit of Measure : ml/second
Time frame: 2 weeks
recurrence of stricture urethra
recurrence of stricture urethra measured by ascending urethrogram and uroflowmetry
Time frame: 2 years
This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Platelet rich plasma